⌘K
Loading ticker…
As of 2026-08-21, Exicure, Inc. Common Stock (XCUR) has a 3-month relative strength percentile of 5 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 27. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 10.8%, relative volume 3.75×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
XCUR is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -37.4% / -68.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
XCUR is held by 2 ETFs as of Mar 2026. Top owner: VXF at 0.00% weight, $123K notional.
Held by 3 ETFs · $163K across latest filings · largest weight 0.00% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $123K | — |
| VTIVanguard Total Stock Market ETF | 0.00% | $18K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XCUR Jan avg: -6.75% median: -12.36% win: 25% σ: 20.94% n: 4 2022-04-12 → 2026-07-31 | XCUR Feb avg: -2.57% median: -11.98% win: 25% σ: 23.02% n: 4 2022-04-12 → 2026-07-31 | XCUR Mar avg: 3.68% median: -0.77% win: 50% σ: 29.91% n: 4 2022-04-12 → 2026-07-31 | XCUR Apr avg: -13.55% median: -21.02% win: 20% σ: 14.91% n: 5 2022-04-12 → 2026-07-31 | XCUR May avg: -7.76% median: -5.55% win: 0% σ: 4.10% n: 5 2022-04-12 → 2026-07-31 | XCUR Jun avg: -17.80% median: -28.67% win: 20% σ: 37.89% n: 5 2022-04-12 → 2026-07-31 | XCUR Jul avg: -6.25% median: -21.37% win: 40% σ: 26.38% n: 5 2022-04-12 → 2026-07-31 | XCUR Aug avg: -7.52% median: -10.86% win: 25% σ: 14.53% n: 4 2022-04-12 → 2026-07-31 (current) | XCUR Sep avg: 3.49% median: -17.54% win: 25% σ: 48.72% n: 4 2022-04-12 → 2026-07-31 | XCUR Oct avg: -6.63% median: -10.71% win: 25% σ: 9.63% n: 4 2022-04-12 → 2026-07-31 | XCUR Nov avg: 202.84% median: -15.91% win: 25% σ: 447.09% n: 4 2022-04-12 → 2026-07-31 | XCUR Dec avg: 4.23% median: 20.44% win: 75% σ: 39.08% n: 4 2022-04-12 → 2026-07-31 |